Abstract
Ferroptosis is a unique form of iron-dependent cell death induced by lipid peroxidation and subsequent plasma membrane rupture, which sets it apart from other types of regulated cell death. Ferroptosis has been linked to a diverse range of biological processes, such as aging, immunity, and cancer. Organoids, on the other hand, are three-dimensional (3D) miniaturized model systems of different organs in vitro cultures, which have gained widespread interest for modeling tissue development and disease, drug screening, and cell therapy. Organoids offer tremendous potential for improving our understanding of human diseases, particularly in the search for the field of ferroptosis in pathological processes of organs. Furthermore, cancer organoids are utilized to investigate molecular mechanisms and drug screening in vitro due to the anti-tumor effect of ferroptosis. Currently, the development of liver organoids has reached a relatively mature stage. Here, we present the protocols for the generation of liver organoids and liver cancer organoids, along with the methods for detecting ferroptosis in organoids.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Dixon SJ, Lemberg KM, Lamprecht MR et al (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149:1060–1072
Guo J, Zhou Y, Liu D et al (2022) Mitochondria as multifaceted regulators of ferroptosis. Life Metab 1:134–148
Stockwell BR, Friedmann Angeli JP, Bayir H et al (2017) Ferroptosis: a regulated cell death nexus linking metabolism, redox biology, and disease. Cell 171:273–285
Tang D, Chen X, Kang R et al (2021) Ferroptosis: molecular mechanisms and health implications. Cell Res 31:107–125
Sato T, Vries RG, Snippert HJ et al (2009) Single Lgr5 stem cells build crypt-villus structures in vitro without a mesenchymal niche. Nature 459:262–265
Rossi G, Manfrin A, Lutolf MP (2018) Progress and potential in organoid research. Nat Rev Genet 19:671–687
Hu H, Gehart H, Artegiani B et al (2018) Long-term expansion of functional mouse and human hepatocytes as 3D organoids. Cell 175(1591–606):e19
Qian X, Nguyen HN, Song MM et al (2016) Brain-region-specific organoids using mini-bioreactors for modeling ZIKV exposure. Cell 165:1238–1254
Fujii M, Matano M, Toshimitsu K et al (2018) Human intestinal organoids maintain self-renewal capacity and cellular diversity in niche-inspired culture condition. Cell Stem Cell 23:787–93.e6
Morizane R, Lam AQ, Freedman BS et al (2015) Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat Biotechnol 33:1193–1200
Broutier L, Mastrogiovanni G, Verstegen MM et al (2017) Human primary liver cancer-derived organoid cultures for disease modeling and drug screening. Nat Med 23:1424–1435
Shinozawa T, Kimura M, Cai Y et al (2021) High-Fidelity drug-induced liver injury screen using human pluripotent stem cell-derived organoids. Gastroenterology 160:831–46.e10
Chen X, Comish PB, Tang D et al (2021) Characteristics and biomarkers of Ferroptosis. Front Cell Dev Biol 9:637162
Chen F, Cai X, Kang R et al (2023) Autophagy-dependent ferroptosis in cancer. Antioxid Redox Signal. https://doi.org/10.1089/ars.2022.0202. Epub ahead of print
Chen X, Comish PB, Tang D, Kang R (2021) Characteristics and Biomarkers of Ferroptosis. Front Cell Dev Biol. 9:637162
Deng F, Zhao BC, Yang X et al (2021) The gut microbiota metabolite capsiate promotes Gpx4 expression by activating TRPV1 to inhibit intestinal ischemia reperfusion-induced ferroptosis. Gut Microbes 13:1–21
Mun SJ, Ryu JS, Lee MO et al (2019) Generation of expandable human pluripotent stem cell-derived hepatocyte-like liver organoids. J Hepatol 71:970–985
Olgasi C, Cucci A, Follenzi A (2020) iPSC-derived liver organoids: a journey from drug screening, to disease modeling, arriving to regenerative medicine. Int J Mol Sci 21:6215
Dutta D, Heo I, Clevers H (2017) Disease modeling in stem cell-derived 3D organoid systems. Trends Mol Med 23:393–410
Lancaster MA, Knoblich JA (2014) Organogenesis in a dish: modeling development and disease using organoid technologies. Science 345:1247125
Kleinman HK, Martin GR (2005) Matrigel: basement membrane matrix with biological activity. Semin Cancer Biol 15:378–386
Kratochvil MJ, Seymour AJ, Li TL et al (2019) Engineered materials for organoid systems. Nat Rev Mater 4:606–622
Aisenbrey EA, Murphy WL (2020) Synthetic alternatives to matrigel. Nat Rev Mater 5:539–551
Si-Tayeb K, Noto FK, Nagaoka M et al (2010) Highly efficient generation of human hepatocyte-like cells from induced pluripotent stem cells. Hepatology 51:297–305
Drost J, Clevers H (2018) Organoids in cancer research. Nat Rev Cancer 18:407–418
Meng Y, Sun J, Zhang G et al (2022) The three-dimension preclinical models for ferroptosis monitoring. Front Bioeng Biotechnol 10:1020971
Ben-David U, Ha G, Tseng YY et al (2017) Patient-derived xenografts undergo mouse-specific tumor evolution. Nat Genet 49:1567–1575
Li M, Izpisua Belmonte JC (2019) Organoids - preclinical models of human disease. N Engl J Med 380:569–579
Nuciforo S, Fofana I, Matter MS et al (2018) Organoid models of human liver cancers derived from tumor needle biopsies. Cell Rep 24:1363–1376
Sun L, Wang Y, Cen J et al (2019) Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes. Nat Cell Biol 21:1015–1026
Tang D, Kroemer G (2020) Ferroptosis. Curr Biol 30:R1292-r7
Lorenzato A, Magrì A, Matafora V et al (2020) Vitamin C restricts the emergence of acquired resistance to EGFR-targeted therapies in colorectal cancer. Cancers 12:685
Guo J, Duan L, He X et al (2021) A combined model of human iPSC-derived liver organoids and hepatocytes reveals ferroptosis in DGUOK mutant mtDNA depletion syndrome. Adv Sci (Weinh) 8:2004680
Ouyang S, Li H, Lou L et al (2022) Inhibition of STAT3-ferroptosis negative regulatory axis suppresses tumor growth and alleviates chemoresistance in gastric cancer. Redox Biol 52:102317
Zhang Q, Deng T, Zhang H et al (2022) Adipocyte-derived exosomal MTTP suppresses Ferroptosis and promotes chemoresistance in colorectal cancer. Adv Sci (Weinh) 9:e2203357
Zou Y, Zheng S, Xie X et al (2022) N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer. Nat Commun 13:2672
Jiang X, Stockwell BR, Conrad M (2021) Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol 22:266–282
Stockwell BR (2022) Ferroptosis turns 10: emerging mechanisms, physiological functions, and therapeutic applications. Cell 185:2401–2421
Chen X, Li J, Kang R et al (2021) Ferroptosis: machinery and regulation. Autophagy 17:2054–2081
Zheng J, Conrad M (2020) The metabolic underpinnings of Ferroptosis. Cell Metab 32:920–937
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Li, W., Su, Y., Guo, J., Wang, M., Liu, X. (2023). Generation of Organoids and Analysis of Ferroptosis in Organoids. In: Kroemer, G., Tang, D. (eds) Ferroptosis. Methods in Molecular Biology, vol 2712. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-3433-2_11
Download citation
DOI: https://doi.org/10.1007/978-1-0716-3433-2_11
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-3432-5
Online ISBN: 978-1-0716-3433-2
eBook Packages: Springer Protocols